{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:20:32Z","timestamp":1755800432780,"version":"3.44.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,20]]},"DOI":"10.7759\/cureus.90549","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T08:55:07Z","timestamp":1755680107000},"source":"Crossref","is-referenced-by-count":0,"title":["Beneficial Effects of Pulse Methylprednisolone Therapy in COVID-19 Patients at Risk of Hyperinflammatory Response"],"prefix":"10.7759","author":[{"given":"Jeevitha","family":"Dandiganahalli Channappa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagadeesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"WHO coronavirus (COVID-19) dashboard. (2021). Accessed. September 2, 2021: https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25689","article-title":"Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China","volume":"92","author":"Wang W","year":"2020","unstructured":"Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol. 2020, 92:441-7. 10.1002\/jmv.25689","journal-title":"J Med Virol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-020-0530-3","article-title":"COVID-19 infection: the perspectives on immune responses","volume":"27","author":"Shi Y","year":"2020","unstructured":"Shi Y, Wang Y, Shao C, et al.. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020, 27:1451-4. 10.1038\/s41418-020-0530-3","journal-title":"Cell Death Differ"},{"key":"ref4","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet Lond Engl. 2020, 395:497-506.","journal-title":"Lancet Lond Engl"},{"key":"ref5","unstructured":"Types of COVID-19 treatment. (2020). Accessed. September 2, 2021: https:\/\/www.cdc.gov\/covid\/treatment\/index.html."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu C","year":"2020","unstructured":"Wu C, Chen X, Cai Y, et al.. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020, 180:934-43. 10.1001\/jamainternmed.2020.0994","journal-title":"JAMA Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2020.1804365","article-title":"Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis","volume":"14","author":"Hasan SS","year":"2020","unstructured":"Hasan SS, Capstick T, Ahmed R, Kow CS, Mazhar F, Merchant HA, Zaidi ST. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med. 2020, 14:1149-63. 10.1080\/17476348.2020.1804365","journal-title":"Expert Rev Respir Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby P","year":"2021","unstructured":"Horby P, Lim WS, Emberson JR, et al.. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021, 384:693-704. 10.1056\/NEJMoa2021436","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03400-9","article-title":"Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes","volume":"24","author":"van Paassen J","year":"2020","unstructured":"van Paassen J, Vos JS, Hoekstra EM, Neumann KM, Boot PC, Arbous SM. Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes. Crit Care. 2020, 24:696. 10.1186\/s13054-020-03400-9","journal-title":"Crit Care"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.82.6.704","article-title":"Systemic corticosteroid therapy--side effects and their management","volume":"82","author":"Stanbury RM","year":"1998","unstructured":"Stanbury RM, Graham EM. Systemic corticosteroid therapy--side effects and their management. Br J Ophthalmol. 1998, 82:704-8. 10.1136\/bjo.82.6.704","journal-title":"Br J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02808-2020","article-title":"Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial","volume":"56","author":"Edalatifard M","year":"2020","unstructured":"Edalatifard M, Akhtari M, Salehi M, et al.. Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial. Eur Respir J. 2020, 56:2002808. 10.1183\/13993003.02808-2020","journal-title":"Eur Respir J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2009.04322.x","article-title":"Prevention and treatment of systemic glucocorticoid side effects","volume":"49","author":"Moghadam-Kia S","year":"2010","unstructured":"Moghadam-Kia S, Werth VP. Prevention and treatment of systemic glucocorticoid side effects. Int J Dermatol. 2010, 49:239-48. 10.1111\/j.1365-4632.2009.04322.x","journal-title":"Int J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2020.601939","article-title":"The hypothalamic-pituitary-adrenal axis: development, programming actions of hormones, and maternal-fetal interactions","volume":"14","author":"Sheng JA","year":"2020","unstructured":"Sheng JA, Bales NJ, Myers SA, Bautista AI, Roueinfar M, Hale TM, Handa RJ. The hypothalamic-pituitary-adrenal axis: development, programming actions of hormones, and maternal-fetal interactions. Front Behav Neurosci. 2020, 14:601939. 10.3389\/fnbeh.2020.601939","journal-title":"Front Behav Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcle.2020.07.002","article-title":"Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection","volume":"155","author":"Callejas Rubio JL","year":"2020","unstructured":"Callejas Rubio JL, Luna del Castillo JD, de la Hera Fern\u00e1ndez J, Guirao Arrabal E, Colmenero Ruiz M, Ortego Centeno N. Effectiveness of corticoid pulses in patients with cytokine storm syndrome induced by SARS-CoV-2 infection. Med Clin (Engl Ed). 2020, 155:159-61. 10.1016\/j.medcle.2020.07.002","journal-title":"Med Clin (Engl Ed)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243964","article-title":"High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response","volume":"16","author":"L\u00f3pez Z\u00fa\u00f1iga M\u00c1","year":"2021","unstructured":"L\u00f3pez Z\u00fa\u00f1iga M\u00c1, Moreno-Moral A, Oca\u00f1a-Granados A, et al.. High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response. PLoS One. 2021, 16:e0243964. 10.1371\/journal.pone.0243964","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.10.008","article-title":"Protracted febrile myalgia syndrome treated with pulse of corticosteroids","volume":"47","author":"Rom E","year":"2018","unstructured":"Rom E, Amarilyo G, Levinski Y, Bilavsky E, Goldberg O, Amir J, Harel L. Protracted febrile myalgia syndrome treated with pulse of corticosteroids. Semin Arthritis Rheum. 2018, 47:897-9. 10.1016\/j.semarthrit.2017.10.008","journal-title":"Semin Arthritis Rheum"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V86.8.3181.3181","article-title":"Glucocorticoids inhibit apoptosis of human neutrophils","volume":"86","author":"Liles WC","year":"1995","unstructured":"Liles WC, Dale DC, Klebanoff SJ. Glucocorticoids inhibit apoptosis of human neutrophils. Blood. 1995, 86:3181-8.","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2006.04.567","article-title":"Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors","volume":"120","author":"Rozkova D","year":"2006","unstructured":"Rozkova D, Horvath R, Bartunkova J, Spisek R. Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors. Clin Immunol. 2006, 120:260-71. 10.1016\/j.clim.2006.04.567","journal-title":"Clin Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the `Cytokine Storm' in COVID-19","volume":"80","author":"Ye Q","year":"2020","unstructured":"Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19. J Infect. 2020, 80:607-13. 10.1016\/j.jinf.2020.03.037","journal-title":"J Infect"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/art.20583","article-title":"Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action","volume":"50","author":"Buttgereit F","year":"2004","unstructured":"Buttgereit F, Straub RH, Wehling M, Burmester GR. Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action. Arthritis Rheum. 2004, 50:3408-17. 10.1002\/art.20583","journal-title":"Arthritis Rheum"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9038","article-title":"Pulse therapy with corticosteroids and intravenous immunoglobulin in the management of severe tocilizumab-resistant COVID-19: a report of three clinical cases","volume":"12","author":"Sheianov MV","year":"2020","unstructured":"Sheianov MV, Udalov YD, Ochkin SS, Bashkov AN, Samoilov AS. Pulse therapy with corticosteroids and intravenous immunoglobulin in the management of severe tocilizumab-resistant COVID-19: a report of three clinical cases. Cureus. 2020, 12:e9038. 10.7759\/cureus.9038","journal-title":"Cureus"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2020.101221","article-title":"Methylprednisolone pulse therapy: an alternative management of severe COVID-19","volume":"31","author":"Sau\u00f1e PM","year":"2020","unstructured":"Sau\u00f1e PM, Bryce-Alberti M, Portmann-Baracco AS, Accinelli RA. Methylprednisolone pulse therapy: an alternative management of severe COVID-19. Respir Med Case Rep. 2020, 31:101221. 10.1016\/j.rmcr.2020.101221","journal-title":"Respir Med Case Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4081\/mrm.2021.781","article-title":"Identification of patients with COVID-19 who are optimal for methylprednisolone pulse therapy","volume":"16","author":"Ro S","year":"2021","unstructured":"Ro S, Nishimura N, Imai R, et al.. Identification of patients with COVID-19 who are optimal for methylprednisolone pulse therapy. Multidiscip Respir Med. 2021, 16:781. 10.4081\/mrm.2021.781","journal-title":"Multidiscip Respir Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252057","article-title":"Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia","volume":"16","author":"Pinz\u00f3n MA","year":"2021","unstructured":"Pinz\u00f3n MA, Ortiz S, Holgu\u00edn H, et al.. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia. PLoS One. 2021, 16:e0252057. 10.1371\/journal.pone.0252057","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239401","article-title":"Second week methyl-prednisolone pulses improve prognosis in patients with severe coronavirus disease 2019 pneumonia: an observational comparative study using routine care data","volume":"15","author":"Ruiz-Irastorza G","year":"2020","unstructured":"Ruiz-Irastorza G, Pijoan JI, Bereciartua E, et al.. Second week methyl-prednisolone pulses improve prognosis in patients with severe coronavirus disease 2019 pneumonia: an observational comparative study using routine care data. PLoS One. 2020, 15:e0239401. 10.1371\/journal.pone.0239401","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.opresp.2021.100086","article-title":"Repeated pulses of methyl-prednisolone in adults hospitalized with COVID-19 pneumonia and acute respiratory distress syndrome: a preliminary before-after study (CortiCOVID study)","volume":"3","author":"Espinosa-Solano M","year":"2021","unstructured":"Espinosa-Solano M, Gonzalez-Vergara D, Ferrer-Galvan M, et al.. Repeated pulses of methyl-prednisolone in adults hospitalized with COVID-19 pneumonia and acute respiratory distress syndrome: a preliminary before-after study (CortiCOVID study). Open Respir Arch. 2021, 3:100086. 10.1016\/j.opresp.2021.100086","journal-title":"Open Respir Arch"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6637227","article-title":"Corticosteroid pulses for hospitalized patients with COVID-19: effects on mortality","volume":"2021","author":"Cusacovich I","year":"2021","unstructured":"Cusacovich I, Aparisi \u00c1, Marcos M, et al.. Corticosteroid pulses for hospitalized patients with COVID-19: effects on mortality. Mediators Inflamm. 2021, 2021:6637227. 10.1155\/2021\/6637227","journal-title":"Mediators Inflamm"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104370","article-title":"Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19","volume":"127","author":"Liu F","year":"2020","unstructured":"Liu F, Li L, Xu M, et al.. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020, 127:104370. 10.1016\/j.jcv.2020.104370","journal-title":"J Clin Virol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy","volume":"19","author":"Toniati P","year":"2020","unstructured":"Toniati P, Piva S, Cattalini M, et al.. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020, 19:102568. 10.1016\/j.autrev.2020.102568","journal-title":"Autoimmun Rev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14820","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Arachchillage DR","year":"2020","unstructured":"Arachchillage DR, Laffan M. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020, 18:1233-4. 10.1111\/jth.14820","journal-title":"J Thromb Haemost"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen N","year":"2020","unstructured":"Chen N, Zhou M, Dong X, et al.. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020, 395:507-13. 10.1016\/S0140-6736(20)30211-7","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1177","article-title":"Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019 (COVID-19; Metcovid): a randomized, double-blind, phase IIb, placebo-controlled trial","volume":"72","author":"Jeronimo CM","year":"2021","unstructured":"Jeronimo CM, Farias ME, Val FF, et al.. Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019 (COVID-19; Metcovid): a randomized, double-blind, phase IIb, placebo-controlled trial. Clin Infect Dis. 2021, 72:e373-81. 10.1093\/cid\/ciaa1177","journal-title":"Clin Infect Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01168-20","article-title":"A retrospective controlled cohort study of the impact of glucocorticoid treatment in SARS-CoV-2 infection mortality","volume":"64","author":"Fern\u00e1ndez-Cruz A","year":"2020","unstructured":"Fern\u00e1ndez-Cruz A, Ruiz-Antor\u00e1n B, Mu\u00f1oz-G\u00f3mez A, et al.. A retrospective controlled cohort study of the impact of glucocorticoid treatment in SARS-CoV-2 infection mortality. Antimicrob Agents Chemother. 2020, 64:e01168-20. 10.1128\/AAC.01168-20","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/349922-beneficial-effects-of-pulse-methylprednisolone-therapy-in-covid-19-patients-at-risk-of-hyperinflammatory-response","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T08:55:10Z","timestamp":1755680110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/349922-beneficial-effects-of-pulse-methylprednisolone-therapy-in-covid-19-patients-at-risk-of-hyperinflammatory-response"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.90549","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,8,20]]}}}